Skin and soft tissue infections in Latin American medical centers: Four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns

Diagnostic Microbiology and Infectious Disease

Volumn 44, Issue 3, 2002, Pages 281-288

  Sader, Helio S ^a   Jones, Ronald N ^b,c   Silva, Juliana B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b JMI LABORATORIES   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; GARENOXACIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINUPRISTIN; RIFAMPICIN; STREPTOMYCIN; TAZOBACTAM; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; GENOTYPE; GEOGRAPHY; GRAM NEGATIVE BACTERIUM; KLEBSIELLA; LABORATORY; MOLECULAR BIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RIBOTYPING; SKIN INFECTION; SOFT TISSUE INFECTION; SOUTH AND CENTRAL AMERICA; STAPHYLOCOCCUS AUREUS; TIME;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS; GRAM-NEGATIVE BACTERIA; HOSPITALS; HUMANS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SENTINEL SURVEILLANCE; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCUS;

EID: 0036862661     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00468-6     Document Type: Article

References (13)

1. Diekema D.J., Pfaller M.A., Jones R.N., Doern G.V., Winokur P.L., Gales A.C., Sader H.S., Kugler K.C., Beach M.L. Survey of bloodstream infections due to gram-negative bacilli frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program . Clin Infect Dis. 29:1999;595-607.
2. Doern G.V., Jones R.N., Pfaller M.A., Kugler K.C., Beach M.L. Bacterial pathogens isolated from patients with skin and soft tissue infections Frequency of occurrence and antimicrobial susceptbility patterns from the SENTRY Antimicrobail Surveillance Program (United States and Canada, 1997) . Diagn Microbiol Infect Dis. 34:1999;65-72.
3. Fung-Tomc J.C., Minassian B., Kolek B., Huczko E., Aleksunes L., Stickle T., Washo T., Gradelski E., Valera L., Bonner D.P. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756. Antimicrob Agents Chemother. 44:2000;3351-3356.
4. Gales A.C., Jones R.N., Pfaller M.A., Gordon K.A., Sader H.S. Two year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals results from the SENTRY Antimicrobial Surveillance Program . Int J Infect Dis. 4:2000;75-84.
5. Jones R.N., Ballow C.H., Biedenbach D.J., Deinhart J.A., Schentag J.J. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada. Diagn Microbiol Infect Dis. 31:1998;437-451.
6. Martone W.J., Nichols R.L. Recognition, prevention, surveillance, and management of surgical site infections. Clini Infect Dis. 33:(Supp 1):2001;S67-S106.
7. Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A5. 2000;National Committee for Clinical Laboratory Standards.
8. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement M100-S12. 2002;National Committee for Clinical Laboratory Standards, Wayne, PA.
9. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Kugler K.C., Beach M.L. Survey of blood stream infections attributable to gram-positive cocci frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program . Diagn Microbiol Infect Dis. 33:1999;283-297.
10. Pfaller M.A., Wendt C., Hollis R.J. Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. Diagn Microbiol Infect Dis. 25:1996;1-8.
11. Sader H.S., Jones R.N., Ballow C.H., Biedenbach D.J., Cereda R.F. Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America results from the Global SMART (GSMART) Surveillance Study . Brazilian Journal of Infectious Disease. 5:2001;21-30.
12. Sader H.S., Jones R.N., Gales A.C., Klugler K., Pfaller M.A., Doern G.V. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia results from the SENTRY Antimicrobial Surveillance Program (1997) . Diagn Microbiol Infect Dis. 32:1998;289-301.
13. Toleman, M. A., Simm, A., Murphy, T. A., Gales, A. C., Biedenbach, D. J., Jones, R. N., Walsh, T. R. (2002). Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. Journal of Antimicrobial Chemotherapy (in press).